Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615703 · ClinicalTrials.gov registry record
Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors
A clinical trial, sponsored by Supernus Pharmaceuticals.
- Completed
- Registry status
- 17
- Enrollment target
NCT03615703 is a clinical trial that has completed, run by Supernus Pharmaceuticals. The registered enrollment target is 17 participants.
The verdict
NCT03615703 has completed, sponsored by Supernus Pharmaceuticals.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-08-10 |
| Est. Completion | 2019-03-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615703
The ClinicalTrials.gov registry entry for NCT03615703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Supernus Pharmaceuticals, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03615703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03615703 about?
NCT03615703 is a clinical study titled "Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors". The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).
What is the current status of trial NCT03615703?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2018-08-10. Estimated completion is 2019-03-15.
Who is sponsoring clinical trial NCT03615703?
This trial is sponsored by Supernus Pharmaceuticals, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.